National reduction in cerebral arteriovenous malformation treatment correlated with increased rupture incidence
- PMID: 35902235
- PMCID: PMC10306162
- DOI: 10.1136/jnis-2022-019110
National reduction in cerebral arteriovenous malformation treatment correlated with increased rupture incidence
Abstract
Background: Recently, there has been a shift in management of unruptured cerebral arteriovenous malformations (AVMs) following studies suggesting that medical management alone was superior to interventional therapy.
Objective: To evaluate the influence of contemporary AVM management on AVM rupture patterns in the United States.
Methods: 154 297 AVM admissions were identified between 2003 and 2017 in the National Inpatient Sample. Annual AVM intervention and rupture rates were computed and multivariable logistic regression assessed the likelihood of AVM intervention pre- and post-2014. Segmented regression identified significant change points and fitted segmented linear models for annual intervention and rupture rates. Correlation coefficients assessed the relationship between annual AVM intervention and rupture rates.
Results: For unruptured AVMs, intervention likelihood and proportion decreased after 2014 (28.1% to 22.3%, p<0.0001; adjusted OR=0.857, 95% CI 0.751 to 0.977, p=0.02). Ruptured AVM admissions increased from 14.7% to 18.6% after 2014 (p<0.0001). Between 2003 and 2017, segmented linear regression identified one significant change point in intervention rate between 2014 and 2015. Average annual percent change for rupture incidence and intervention rate increased by 0.49% (p=0.0001) and decreased by 1.17% (p=0.0001), respectively. Annual AVM intervention rates were inversely correlated with annual AVM rupture incidence (Pearson coefficient=-0.82, p=0.0002). In 2017, the annual AVM rupture rate (20.6%) surpassed the annual AVM intervention rate (19.7%).
Conclusions: After 2014, the likelihood of intervention for unruptured AVMs decreased while the incidence of ruptured AVMs increased. These findings suggest that fewer unruptured AVM treatments may lead to increases in AVM rupture incidence.
Keywords: arteriovenous malformation; embolic; hemorrhage; malformation; vascular malformation.
© Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ.
Conflict of interest statement
Competing interests: None declared.
Figures
References
-
- Ding D, Starke RM, Kano H, Mathieu D, Huang PP, Kondziolka D, et al. Stereotactic radiosurgery for aruba (a randomized trial of unruptured brain arteriovenous malformations)-eligible spetzler-martin grade i and ii arteriovenous malformations: A multicenter study. World Neurosurg 2017;102:507–517 - PubMed
-
- Hong CS, Peterson EC, Ding D, Sur S, Hasan D, Dumont AS, et al. Intervention for a randomized trial of unruptured brain arteriovenous malformations (aruba) - eligible patients: An evidence-based review. Clin Neurol Neurosurg 2016;150:133–138 - PubMed
-
- Karlsson B, Jokura H, Yang HC, Yamamoto M, Martinez R, Kawagishi J, et al. The nassau (new assessment of cerebral arteriovenous malformations yet unruptured) analysis: Are the results from the aruba trial also applicable to unruptured arteriovenous malformations deemed suitable for gamma knife surgery? Neurosurgery 2019;85:E118–E124 - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources